Tai Sandi See

Insider Reports History

Location
New York, NY
Signature
/s/ Youjin Choi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tai Sandi See:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Development Officer Common Stock 65,476 $606,962 $9.27 18 Nov 2025 Direct
Lexeo Therapeutics, Inc. Chief Development Officer Stock Option (right to buy) 77,500 07 Jan 2025 Direct

Insider Reports Filed by Tai Sandi See

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LXEO Lexeo Therapeutics, Inc. 18 Nov 2025 1 -$3,578 4 Chief Development Officer 20 Nov 2025, 17:19
LXEO Lexeo Therapeutics, Inc. 15 Oct 2025 3 -$34,767 4 Chief Development Officer 17 Oct 2025, 19:29
LXEO Lexeo Therapeutics, Inc. 18 Aug 2025 1 -$1,783 4 Chief Development Officer 20 Aug 2025, 16:58
LXEO Lexeo Therapeutics, Inc. 16 May 2025 1 -$1,018 4 Chief Development Officer 20 May 2025, 17:00
LXEO Lexeo Therapeutics, Inc. 14 Mar 2025 1 +$14,929 4 Chief Development Officer 09 Apr 2025, 17:44
LXEO Lexeo Therapeutics, Inc. 19 Feb 2025 1 -$6,558 4 Chief Development Officer 21 Feb 2025, 17:09
LXEO Lexeo Therapeutics, Inc. 07 Jan 2025 2 $0 4 Chief Development Officer 10 Jan 2025, 16:55
LXEO Lexeo Therapeutics, Inc. 05 Feb 2024 0 $0 3 Chief Development Officer 06 Feb 2024, 17:58